Loading...
*  A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance...
Use of any anti-HIV agents, other than drugs in the qualifying triple antiretroviral regimen, within the past 16 weeks.] ... Documentation of a 3-fold rise in plasma HIV RNA level (using the same assay) or a previously documented plasma HIV RNA at an ... Documentation of either a plasma HIV RNA , 50,000 copies/ml by the Roche Amplicor HIV-1 assay or , 25,000 copies/ml by the ... AS PER AMENDMENT 9/17/97: Documentation of either a plasma HIV RNA level ,20,000 copies/ml by the Roche Amplicor HIV-1 assay or ...
  https://clinicaltrials.gov/show/NCT00000874?order=580
*  A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation - Full Text View -...
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... Anti-HIV drug therapy works best when the drugs are taken exactly as prescribed by a doctor. Because anti-HIV therapy often ... Have not taken anti-HIV drugs for more than 7 days. *Agree to use acceptable methods of contraception during the study and for ... A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation. This study has been ...
  https://clinicaltrials.gov/show/NCT00036452?order=253
*  Atazanavir/r + Lamivudine Dual Therapy - Full Text View - ClinicalTrials.gov
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... HIV infection. Atazanavir. Lamivudine. Ritonavir. virological suppression. non-inferiority. Combined antiretroviral therapy. ... HIV Infections. Immune System Diseases. Lentivirus Infections. Retroviridae Infections. RNA Virus Infections. Virus Diseases. ... HIV positive patients 18 years of age or older who signed an informed consent form ...
  https://clinicaltrials.gov/show/NCT01599364?order=51
*  Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents - Full Text View -...
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... HIV Protease Inhibitors. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Pharmacokinetics. Treatment Experienced. Treatment ... Advancements in anti-HIV drugs for HIV infected children and adolescents have been hard to make, in part because these patients ... Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents. This study has ...
  https://clinicaltrials.gov/ct2/show/study/NCT00006604?view=results
*  Recent Studies on Natural Products as Anti-HIV Agents: Ingenta Connect
HIV) is urgently needed due to its globally widespread infection. Most of clinically useful anti-HIV agents are nucleosides but ... Keywords: Alkaloids; Anti HIV Agents; Carbohydrates; Trikendiol; allanthus altissima; anolignan A; artemisinin; batzelladines A ... Over the past decade, substantial progress has been made in research on the natural products for the anti-HIV agents. New ... Natural products, of which structural diversity is so broad, are good sources for the effective discovery of anti-HIV agents ...
  http://www.ingentaconnect.com/content/ben/cmc/2000/00000007/00000006/art00004
*  IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults - Full Text View ...
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... Treatment with any anti-HIV or non-ARV drug that could interact with drugs under pharmacokinetic (PK) study in the 14 days ... This study will examine drug and body interactions in children receiving anti-HIV treatment regimens using new medications. ... Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention. MMWR ...
  https://clinicaltrials.gov/show/NCT00977756?order=647
*  NIH Guide: PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANTI-HIV AGENTS
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND ANTI-HIV AGENTS NIH GUIDE, Volume 23, Number 3, January 21, 1994 RFP ... pharmacology studies in non-disease bearing animals on agents having demonstrated antitumor or anti-HIV activity and considered ... The Government will supply all animals (mice, rats, dogs, non-human primates), test agents, and radiolabeled test agents. ... The studies to be performed will include: the development of methodology for the quantitative measurement of test agents and/or ...
  https://grants.nih.gov/grants/guide/notice-files/not94-035.html
*  Anti-HIV Agents | GreenMedInfo | Pharmacological Action | Natural
Anti-HIV Agents, Anti-Retroviral Agents. Additional Keywords : Anti-HIV Agents, Anti-Retroviral Agents, HIV Infections, ... Diseases : HIV Infections. Pharmacological Actions : Anti-HIV Agents, Antiviral Agents, Enzyme Inhibitors, HIV Protease ... Pharmacological Actions : Anti-HIV Agents, Antioxidants, HIV Protease Inhibitors. Additional Keywords : Drug: Zidovudine, Plant ... Pharmacological Actions : Anti-HIV Agents, Antineoplastic Agents, Antiproliferative , Apoptotic. Additional Keywords : Fungal ...
  http://www.greenmedinfo.com/pharmacological-action/anti-hiv-agents
*  Drug Interactions Among Anti-HIV Agents - Full Text View - ClinicalTrials.gov
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... Drug Interactions Among Anti-HIV Agents. The safety and scientific validity of this study is the responsibility of the study ... Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrob Agents Chemother. ... Current or anticipated therapy with other agents with documented activity against HIV-1 in vitro (other than stable maintenance ...
  https://www.clinicaltrials.gov/ct2/show/NCT00001766
*  Yale researchers discover promising anti-HIV agents | YaleNews
These agents could allow for comparatively lower dosages, and also for prophylactic anti-HIV treatment, he said. Importantly, ... This illustration shows a new anti-HIV agent developed at Yale bound to an enzyme essential for the virus' replication. Two ... The new agents work by inhibiting the function of an enzyme essential for HIV's replication. That enzyme is called HIV-1 ... Two of the new agents are extraordinarily potent against the predominant, "wild-type" form of HIV, which is highly adept at ...
  https://news.yale.edu/2011/11/18/yale-researchers-discover-promising-anti-hiv-agents
*  Boehringer Ingelheim Launches Global Phase III Clinical Trials For New Anti-HIV Agent Tipranavir
... ... HIV Drug Resistance The HIV-1 virus acquires HIV drug resistance after sub-optimal exposure to antiretroviral therapy, which ... Resistance to currently available anti-HIV drugs is an increasingly prevalent concern for highly treatment-experienced HIV- ... VIRAMUNE was the first member of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of anti-HIV drugs. Boehringer ...
  http://www.natap.org/2003/feb/020703_4.htm
*  Molecules | Free Full-Text | Mangiferin, an Anti-HIV-1 Agent Targeting Protease and Effective against Resistant Strains
Mechanism studies revealed that mangiferin might inhibit the HIV-1 protease, but is still effective against HIV peptidic ... Mangiferin can inhibit HIV-1ⅢB induced syncytium formation at non-cytotoxic concentrations, with a 50% effective concentration ... A combination of docking and pharmacophore methods clarified possible binding modes of mangiferin in the HIV-1 protease. The ... Mangiferin also showed good activities in other laboratory-derived strains, clinically isolated strains and resistant HIV-1 ...
  https://www.mdpi.com/1420-3049/16/5/4264
*  Yale licenses potential anti-HIV agent to Oncolys BioPharm...( New Haven Conn. - Yale University toda...)
... anti-HIV,agent,to,Oncolys,BioPharma,of,Japan,biological,biology news articles,biology news today,latest biology news,current ... Ed4T is a thymidine analogue that blocks HIV-1 reverse transcriptas... This license agreement was possible because Yale has ... a compound with a new and potentially effective anti-HIV clinical treatment. Ed4T is a thymidine analogue that blocks HIV-1 ... of Tokyo the global exclusive right for clinical and business development of a novel compound for the treatment of HIV.. A ...
  http://news.bio-medicine.org/biology-news-3/Yale-licenses-potential-anti-HIV-agent-to-Oncolys-BioPharma-of-Japan-6163-1/
*  WO2017149511 USE OF 2-OXO-2H-PYRROL-1(5H)-CARBOXAMIDE DERIVATIVES AS ANTI-HIV AGENTS AND PROCESS FOR THE PRODUCTION THEREOF
... carboxamide derivatives in the treatment of HIV infections, pharmaceutical compositions containing these derivatives as active ... EN) USE OF 2-OXO-2H-PYRROL-1(5H)-CARBOXAMIDE DERIVATIVES AS ANTI-HIV AGENTS AND PROCESS FOR THE PRODUCTION THEREOF. (FR) ... 1. (WO2017149511) USE OF 2-OXO-2H-PYRROL-1(5H)-CARBOXAMIDE DERIVATIVES AS ANTI-HIV AGENTS AND PROCESS FOR THE PRODUCTION ... UTILISATION DE DÉRIVÉS DE 2-OXO-2H-PYRROL-L(5H)-CARBOXAMIDE EN TANT QU'AGENTS ANTI-VIH ET PROCÉDÉ DE PRODUCTION ASSOCIÉ. ...
  https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017149511
*  In Vitro Evaluation of Experimental Agents for AntiHIV Activity - Current Protocols
This unit presents an assay that has proven useful as an initial screening test is an HIV cytopathic effect (CPE) inhibition ... strains of HIV are utilized as target cells. Additional protocols assess the antiHIV activity of certain candidate agents by ... In Vitro Evaluation of Experimental Agents for AntiHIV Activity. Douglas D. Richman1, Victoria A. Johnson2, Douglas M. Mayers3 ... In vitro inhibition of HIV‐1 replication by C2 symmetry‐based HIV protease inhibitors as single agents or in combinations. ...
  http://www.currentprotocols.com/WileyCDA/CPUnit/refId-im1209.html?quicktabs_cp=cited
*  HIV anti Latency Agents Pipeline
A lot of anti-latency agents are screened, as well as immuno-modulatory drugs. ... active reserach is ongoing to find an HIV cure. ... hiv eradication HIV reservoirs hiv cure HIV latency hiv ... reservoirs eradication HIV eradication HIV workshop reservoirs hiv persistence reservoir cure HIV HIV cure ISHEID HIV ... Key words: HDAC inhibitors, HIV Gilead, HIV Janssen, HIV cure, HIV cure research, HIV latency, HIV reservoirs ...
  http://www.hiv-reservoir.net/index.php/the-news/193-hiv-anti-latency-agents-pipeline.html
*  Hyssop Plant Extracts Found to Be Potent Anti-HIV Agents
MAR-10 also has broad spectrum anti-glycosidase activity (inhibits HIV from replicating and inhibits HIV-mediated syncytium ... 1) In one study, extracts of dried leaves of Hyssop officinalis showed strong anti-HIV properties. *Hyssop officinalis inhibits ... 2) In another study, a polysaccharide isolated from Hyssop officinalis also showed strong anti-HIV activity.. *The ... This study shows that the polysaccharide MAR-10 has strong anti-HIV-1 activity and can be considered potent in treating people ...
  https://blog.optimalhealthnetwork.com/2014/02/extracts-from-hyssop-officinalis-have.html
*  NF - Anti-HIV Agents, HIV Protease Inhibitors, ATC:J05AE04
Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. ... Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of ... Patients should be informed that VIRACEPT is not a cure for HIV infection and that they may continue to acquire illnesses ... the risk of transmitting HIV to others through sexual contact or blood contamination. Patients should be advised to take ...
  http://pharmacycode.com/NF.html
*  1. Development of a novel ELISA for the testing of glycobioconjugates as anti-HIV agents 2. Synthesis of potential inhibitors...
1. Development of a novel ELISA for the testing of glycobioconjugates as anti-HIV agents 2. Synthesis of potential inhibitors ... 1. Development of a novel ELISA for the testing of glycobioconjugates as anti-HIV agents 2. Synthesis of potential inhibitors ... 1. Development of a novel ELISA for the testing of glycobioconjugates as anti-HIV agents 2. Synthesis of potential inhibitors ... AIDS, or acquired immunodeficiency syndrome, is caused by the human immunodeficiency virus (HIV). HIV is a retrovirus that is ...
  http://arizona.openrepository.com/arizona/handle/10150/283988
*  Novel polypeptide anti-HIV agent containing the same - Patent application
... and an anti-HIV compound: 3'-azido-2',3'-dideoxythymidine (AZT) used as a medicine as a control anti-HIV agent. TABLE-US-00007 ... it can be considered to have an anti-HIV virus activity. It can be also considered, in addition to anti-HIV virus agent, to ... Anti-HIV Activity and Cytotoxicity, [0138]HIV-1 (IIIB) strain obtained from MOLT/HIV-1 (IIIB) cell previously infected by HIV-1 ... Patent application title: Novel polypeptide anti-HIV agent containing the same. Inventors: Nobutaka Fujii Agents: JORDAN AND ...
  http://www.patentsencyclopedia.com/app/20100222256
*  Viramune - Anti-HIV Agents, Nonnucleoside Reverse Transcriptase Inhibitors, ATC:J05AG01
HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by ... It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to ... For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection. ...
  http://pharmacycode.com/Viramune.html
*  EFV - Anti-HIV Agents, Nonnucleoside Reverse Transcriptase Inhibitors, ATC:J05AG03
SUSTIVA must be taken with other anti-HIV medicines. When taken with other anti-HIV medicines, SUSTIVA has been shown to reduce ... HIV-1), the virus that causes AIDS (acquired immune deficiency syndrome). SUSTIVA is a type of anti-HIV drug called a "non- ... Changes in body fat. Changes in body fat develop in some patients taking anti-HIV medicine. These changes may include an ... SUSTIVA must be taken in combination with other anti-HIV medicines. If you take only SUSTIVA, the medicine may stop working. ...
  http://pharmacycode.com/EFV.html
*  Rescriptor - Anti-HIV Agents, Nonnucleoside Reverse Transcriptase Inhibitors, ATC:J05AG02
For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted ... HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by Delavirdine ... with HIV-1 infection, including opportunistic infections. Treatment with RESCRIPTOR has not been shown to reduce the incidence ... Patients should be informed that RESCRIPTOR is not a cure for HIV-1 infection and that they may continue to acquire illnesses ...
  http://pharmacycode.com/Rescriptor.html
*  Scotland Is Not For The Squeamish 2011
pursue You human Anti-Aging Products in Your theories and IDs? new Wrinkle ia have always returned at ermitteln over 40 but ... The Dictionary of Untranslatables offers, for safety, to write on the registration between the others l, Geist, and agent. Or ... For sophistic planets around the site, their greatest agenda of HIV team Is from depending dictionary with the new Download ... The insight you widely noted decentralised the profession user-agent. There have sociocultural institutes that could run this ...
  http://keepergoals.com/Templates/pdf/Scotland-is-not-for-the-squeamish-2011/
*  Get A Discount : Methylprednisolone And Prednisolone Equivalent
C21- hiv-associated l6tx,l7a-isopropylidene patient of concerns and ulcer or prepared in study psychosis lab is drug 1/1 to 5, ... When i said my device, i meant that target, steroidal; cardiologists on the substitute left alkyl of clomid nolva buy my anti- ... Signs to the growing rash class in methylprednisolone acetate usually are conducting unusual agents to ensure healthy side of ... Temperature on medical pneumocystis isohexylidene morning in non-hiv trials. Not, during the doctor hiec, the source is blocked ...
  http://420surveillance.com/dvr-cards/enterprise-cards.html?price=1%2C1000